Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug’s outcomes trial
October 21, 2021
Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug's outcomes trial
aliu
Mon, 10/18/2021 – 10:35
Read the source article at Pharma News
2021-10-18 15:35:41